It’s long before noon, but chemical technicians coach Ralf Scharf is already heading to the company’s dining room. And lunch is the last thing that comes to mind.
He is here to get a COVID-19 shot as his German businessman Evonik Industries joins a push to increase the country’s vaccination drive including the company’s doctors in the effort.
“You can get vaccinated with almost no waiting time, it’s fantastic,” Scharf, 58, told AFP after a short walk from his workstation to the dining room.
The usual tables have been removed to make way for the rows of small cabins they occupy medical staff.
Each section is dedicated to a different step in the process, from signing consent forms and obtaining a prior consultation to the actual injection and recovery room.
Hungry workers can still grab food in the kitchen in an adjoining room.
The makeshift vaccination center at the Hanau site of the Evonik chemical group near Frankfurt is one of several pilot projects in Germany. Railway operator Deutsche Bahn, vehicle manufacturer Volkswagen and chemical giant BASF have launched similar schemes.
The initial official feature for doctors from companies across the country to join coronavirus jabs campaign will arrive on June 7th.
Demand is expected to outstrip supply, at least initially, until larger vaccine shipments gradually reach Germany’s mass vaccination centers, medical offices and participating companies.
After a much-criticized slow start, Germany has significantly increased the rate of inoculation in recent weeks.
About 40 percent of adults have now received the first shot and more than 13 percent have had both blows.
“Light on the horizon”
A Evonik, company Dr. Christine Busch only has a few hundred doses to administer during the pilot phase.
But once the project gets underway next month, he expects to vaccinate about a thousand people a week.
Initially, the focus will be on the approximately 3,500 Evonik employees and employees of partner companies. It is also planned to expand the offer to the family members of the employees.
All strokes in the pilot scheme are Pfizer / BioNTech shots, for which Evonik produces the small fat bubbles known as lipid nanoparticles that protect the crucial mRNA molecules from the vaccine.
As long as the supply of vaccines remains tight, your company prioritizes employees who must be on site and unable to work from home.
“We’ve all been living with this pandemic for over a year,” Busch said.
“Now, for the first time, we can see light on the horizon and actively participate in overcoming that thing. That’s pretty special.”
And, according to Hanau site manager Kerstin Oberhaus, there is no shortage of appetite for bites.
“As soon as I get out of my car in the morning, people approach me wondering when it will be their turn,” he said. “The urge to get vaccinated is huge.”
© 2021 AFP
Citation: Germany offers COVID punches in the company’s dining hall (2021, May 23) recovered on May 23, 2021 at https://medicalxpress.com/news/2021-05-germany-covid-jabs-company-canteen. html
This document is subject to copyright. Apart from any fair treatment for the purposes of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.